Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Switzerland Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20041
20051
20072
20082
20091
20101
20111
20141
20152
20162
20181
20191
20202
20212
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Unknown status5
Active, not recruiting4
Recruiting4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC7
Novartis Pharmaceuticals6
Celgene2
Takeda2
University Hospital, Basel, Switzerland2
Amgen1
Celgene Corporation1
Children's Oncology Group1
European Working Group of MDS in Childhood1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes35
Leukemia, Myelomonocytic, Chronic10
Anemia, Refractory, with Excess of Blasts9
Leukemia, Myeloid, Acute9
Leukemia8
Anemia5
Anemia, Refractory5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Recurrence4
Congenital Abnormalities3

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.